Cantargia AB
STO:CANTA

Watchlist Manager
Cantargia AB Logo
Cantargia AB
STO:CANTA
Watchlist
Price: 1.812 SEK -2.42% Market Closed
Market Cap: 332.8m SEK
Have any thoughts about
Cantargia AB?
Write Note

Cantargia AB
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cantargia AB
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Cantargia AB
STO:CANTA
Interest Income Expense
kr5.5m
CAGR 3-Years
36%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Interest Income Expense
kr27.6m
CAGR 3-Years
N/A
CAGR 5-Years
31%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Interest Income Expense
kr2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Interest Income Expense
-kr82m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Interest Income Expense
-kr1.4B
CAGR 3-Years
-38%
CAGR 5-Years
-47%
CAGR 10-Years
-64%
BioArctic AB
STO:BIOA B
Interest Income Expense
kr12m
CAGR 3-Years
N/A
CAGR 5-Years
26%
CAGR 10-Years
N/A
No Stocks Found

Cantargia AB
Glance View

Market Cap
332.8m SEK
Industry
Biotechnology

Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment. The company is headquartered in Lund, Skane. The company went IPO on 2015-03-17. The firm is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Cantargia AB uses the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia.

CANTA Intrinsic Value
1.024 SEK
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Cantargia AB's Interest Income Expense?
Interest Income Expense
5.5m SEK

Based on the financial report for Sep 30, 2024, Cantargia AB's Interest Income Expense amounts to 5.5m SEK.

What is Cantargia AB's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
45%

Over the last year, the Interest Income Expense growth was -40%. The average annual Interest Income Expense growth rates for Cantargia AB have been 36% over the past three years , 45% over the past five years .

Back to Top